Drug Profile
Recombinant influenza virus vector carrier vaccine (tuberculosis) - Polymun Scientific
Alternative Names: influenza A virus vector carrier vaccine (tubrculosis) - Polymun ScientificLatest Information Update: 28 May 2020
Price :
$50
*
At a glance
- Originator Polymun Scientific
- Class Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Tuberculosis
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 28 May 2020 No recent reports of development identified for preclinical development in Tuberculosis(Prevention) in Austria (Intranasal, Spray)
- 22 Apr 2016 Preclinical trials in Tuberculosis (Prevention) in Austria (Intranasal)